Market Cap

Assembly Biosciences, Inc. Market Capitalization:

$87.3 Million

USD as of July 1, 2024

business Assembly Biosciences, Inc. Company Profile

Assembly Biosciences, Inc. Main Stock Listing

NASDAQ: ASMB

Market Capitalization History of Assembly Biosciences, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Assembly Biosciences, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $53.2 M -25.95%
Jan. 1, 2023 $71.8 M -19.35%
Jan. 1, 2022 $89.0 M -66.67%
Jan. 1, 2021 $267.1 M -68.22%
Jan. 1, 2020 $840.5 M -22.91%
Jan. 1, 2019 $1.09 B -51.72%
Jan. 1, 2018 $2.26 B 154.07%
Jan. 1, 2017 $888.8 M 262.70%
Jan. 1, 2016 $245.1 M -39.05%
Jan. 1, 2015 $402.0 M -60.38%
Jan. 1, 2014 $1.01 B 65.62%
Jan. 1, 2013 $612.6 M -71.24%
Jan. 1, 2012 $2.13 B 45.42%
Jan. 1, 2011 $1.46 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Assembly Biosciences, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Assembly Biosciences, Inc. has the following listings and related stock indices.


Stock: NASDAQ: ASMB

Stock: FSX: V7B1

Stock: XSTU: V7B1

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.